Based in the Netherlands, VarmX is a startup. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
VarmX is a pharmaceutical company developing innovative approaches for the reversal of anticoagulation.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.